Distinct Subgroups in Hypertrophic Cardiomyopathy: Baseline Results From HCMR
暂无分享,去创建一个
N. Geller | S. Piechnik | S. Neubauer | C. Kramer | M. Desai | J. Schulz-Menger | H. Watkins | M. Jerosch-Herold | M. Friedrich | J. Dimarco | W. Weintraub | M. Maron | P. Kolm | Carolyn Y. Ho | E. Appelbaum | P. Desvigne‐Nickens | S. Dolman | C. Zhang | Kim D-Y.
[1] M. Link,et al. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. , 2019, JAMA cardiology.
[2] Joseph Loscalzo,et al. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[3] B. Maron,et al. Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)". , 2019, Circulation.
[4] N. Smedira,et al. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function. , 2018, Journal of the American College of Cardiology.
[5] L. Tavazzi,et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies , 2018, European heart journal.
[6] K. Hayashi,et al. Late Gadolinium Enhancement for Prediction of Mutation-Positive Hypertrophic Cardiomyopathy on the Basis of Panel-Wide Sequencing. , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[7] A. Keren,et al. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM) , 2017, Circulation.
[8] Stefan K. Piechnik,et al. Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects , 2017, Journal of Cardiovascular Magnetic Resonance.
[9] T. Driscoll,et al. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications. , 2017, Circulation. Cardiovascular genetics.
[10] M. Link,et al. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. , 2017, Journal of the American College of Cardiology.
[11] R. Chan,et al. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.
[12] P. Kellman,et al. Native myocardial T1 and ECV with age and gender developing normal reference ranges - a 94 healthy volunteer study , 2016, Journal of Cardiovascular Magnetic Resonance.
[13] Marie Schmidt,et al. Nonparametrics Statistical Methods Based On Ranks , 2016 .
[14] Stefan L. Zimmerman,et al. Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy. , 2015, The American journal of cardiology.
[15] N. Geller,et al. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.
[16] J. Manson,et al. Biomarkers of cardiovascular disease risk in women. , 2015, Metabolism: clinical and experimental.
[17] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.
[18] E. Cook,et al. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.
[19] R. Blankstein,et al. Left Atrial Passive Emptying Function Determined by Cardiac Magnetic Resonance Predicts Atrial Fibrillation Recurrence After Pulmonary Vein Isolation , 2014, Circulation. Cardiovascular imaging.
[20] T. Sugiura,et al. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.
[21] Chia-Ying Liu,et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.
[22] Michael Jerosch-Herold,et al. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. , 2013, JACC. Cardiovascular imaging.
[23] R. Kwong,et al. T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.
[24] Scott D Flamm,et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.
[25] M. Maron,et al. Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.
[26] Francesca N. Delling,et al. Intermediate-Signal-Intensity Late Gadolinium Enhancement Predicts Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[27] Christopher E. Buller,et al. AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy : Executive summary , 2011 .
[28] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[29] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[30] M. Link,et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.
[31] Michael J Ackerman,et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. , 2006, Mayo Clinic proceedings.